Bridging the Gap: Index Volume [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

74 Guatemala * haemophiliacs

12th World AIDS Conference

-Keyword

Abstract

marginal precary area of /The STD/HIV/AIDS clinic wor 43202
rs and other gay men in /Human rights advocacy: Ensu 404*/44146
ng Mayan youths in the Guatemalan highlands/Consciousness ra 13524
Involvement of the non gubernamental organizations in the forma 34371
AIDS survival in French Guiana /AIDS survival in French 13330
mosis survival in French I/Histoplasmosis survival in Frenc 22217
ugh AIDS hotline and a guideline of AIDS education/Survey on se 13509
Implementation of new guidelines for treatment of HIV infection/A 22333
of adherence to clinical and patient outcomes: Exampl 22379
an practices/Treatment in HIV: Self reported physician 24120
IV infected child/Italian for disclosure of diagnosis to HI 24283
borative approach with for care/Adherence to antiretro 32378
d medical management (ATMMGs) of pediatric HIV inf 32439
evelopment of national of STD case management and 33251
erence to government to reduce perinatal transmissio 460*/42210
ctions (Ols) prevention in federally funded health care f 42212
antiretroviral treatment /Worldwide education of prima 42231
treatment in HIV/From to clinical reality: Doctors' and 42293
he HIV clinical practice /The development of a strategi 42411
g new STD surveillance /Designing new STD surveillan 60120
n/International index of on antiretroviral therapies and 60379
phylaxis: Application of /MAC prophylaxis: Application 60471
e presentation of the " for the use of antiretroviral age 60922
n-infected individuals in Guinea-Bissau /Increased levels of P-che 605*/31133
d HIV risk in Papua New Guinea /Love magic and HIV risk in Papua 96*/14318
nd Tamagly stop sites ( )/STD and HIV intervention/aware 43322
nd Tamagly stop sites ( )/Prevention and STD manageme 43372
chool system: Project in Gujarat, India/HIV/AIDS education in the s 13542
men and women in rural, India/Use of repeat interviews to 14304
HIV infected patients in, India/Pattern of tuberculosis (TB) 22162
ors among rural men in,India/Perceptions of sexually tran 33342
mmercial sex workers in Guyana /HIV infection and syphilis among 23538
STD clinic attenders in /Performance of a rapid RPR met 33241
IDS among students in: A framework to design prevention 34239
mily planning clients in /Genital N. gonorrhoeae and C. tr 60783
en in central London gyms /Recruiting peer educators for a com 60810
roids in central London /Injecting behaviour among gay men 60811
Swiss HIV cohort study/ Gynecologic management of women in th 42433
e women/Adherence to gynecologic examinations among HIV po 32132
plications following 191 gynecological and obstetrical surgical int 13391, Brazil/STD and other manifestations - A cross-s 61004
year and HIV testing by gynecologists in a cohort of HIV-infected 32131
enotyping/Nelfinavir in HAART-experienced HIV-1 infected patie 41215
ad in patients receiving HAART - Evidence for a drug sanctuary co 267*/11153
e antiretroviral therapy ( ) on viral dynamics during primary 11155
els in patients receiving in the Frankfurt HIV-Cohort/Progn 12129
ary HIV infection using lead to HIV eradication?/Can dura 12188
anti-retroviral therapy ( )/Naive T cell subsets during acute 12190
ed patients treated with /T lymphocyte dynamics in primar 12194
ccessfully treated with? The EuroSIDA Study/Can proph 12268
e antiretroviral therapy ( )/Determinants of failure of highly 12271
untry (Spain)/lmpact of in a cohort of patients from the Bas 12276
e antiretroviral therapy ( )/Hepatotoxicity after introduction 12288
1 infected patient during /Lymphocyte subsets and function 12302
antiretroviral treatment ( ) on neutrophil and monocyte funct 12322
cific CD4 cell function in patients/Follow-up of antigen-spe 12341
ntiretroviral treatment ( )in France/Clinical manifestations 12345
e antiretroviral therapy ( ) in France: Is AIDS incidence still d 13202
e antiretroviral therapy ( )/Decreases in HIV-related morbid 13239
active antiviral therapy ( ) became prevalent/Time to AIDS 13307
e antiretroviral therapy ( ) on CD4 Ivmphocvte counts in Fra 13318

ntirretroviral treatment (
antiretroviral treatment (
e antiretroviral therapy (
mphoma obtained with
ntiretroviral treatments (
cell homeostasis during
e antiretroviral therapy (
e antiretroviral therapy (
e antiretroviral therapy (
g-term effectiveness of
nd children receiving
vudine and lamivudine (
ntiretroviral therapy (
zation of diagnostic lab/
5000 copies ml during
sts in patients receiving
anti-retroviral therapy (
e antiretroviral therapy (
o antiretroviral therapy (
cted patients receiving
e antiretroviral therapy (
antiretroviral treatment (
ue/Effect of prolonged
e antiretroviral therapy (
ed patients treated with
e antiretroviral therapy (
th AIDS maintained on
and wasting in the era of
e antiretroviral therapy (
e antiretroviral therapy (
e antiretroviral therapy (
osteronism in the era of
antiretroviral therapy (
e antiretroviral therapy (
e antiretroviral therapy (
T-naive HIV+ patients/
e antiretroviral therapy (
e antiretroviral therapy (
antiretroviral therapy (
e antiretroviral therapy (
e antiretroviral therapy (
tiretroviral treatments (
antiretroviral therapy(
e antiretroviral therapy (
e antiretroviral therapy (
anti-retroviral therapy (
rophylaxis (PSEP) with
T) and blood/Effects of
cted patients/Effect of
mia" in patients ongoing
ary CNS lymphoma and
ntiretroviral therapy (
irologic outcomes after
ba, Canada/Impact of
ness of new therapies/
e antiretroviral therapy (
e antiretroviral therapy (
e antiretroviral therapy (
e antiretroviral therapy (
e antiretroviral therapy (
antiretroviral treatment (
e antiretroviral therapy (
e setting/Adherence to
S patients treated with
/Viral load response to
of virologic response to
ntiretroviral treatments (
us retinitis in the age of
e antiretroviral therapy (
V infection treated with
ir + 2 NRTIs as first line
ximising the benefits of
dgkin's lymphoma with
therapy combined with
actic acidosis following

Keyword Abstract
)/Nonprogression of CMV retinitis i 22271
) in patients with AIDS-associated 617*/22275
) in patients with HIV-related non-H 22289
and with interleukin-2 after relapse 22293
)/Early regression of cervical lesio 22312
/Dynamics of mean TRF and T cell 22341
)/Sustained immunologic improve 22342
) increases circulating naive CD8+ 22345
)/Risk factors for virologic failure in 22351
in a large clinical group and the rol 22353
/Switch in HIV phenotype and iden 22358
) in HIV-1 infected children: Kinetic 22362
) and predictors of undetectable pi 22365
and prophylaxis result in further co 22369
(AZT, 3TC, Ind)/Quantitation of HI 22383
despite undetectable plasma virus 22388
)/Changes in lymphocyte subsets 345*/22412
) era/Home care in the highly activ 22449
)/Compliance of HIV positive/PWA 23250
/Sequential changes in erythrocyt 31102
)/Functional lymphocyte reconstit 113*/31134
)/Specific T-cell responses in HIV-i 111*/31142
on immune function and on viral lo 31160
)/Immunologic function and recon 338*/31186
/Discontinue primary prophylaxis r 31225
)/Hematological parameters correl 32139
/Treatment of dorsocervical fat pa 32164
in HIV-infected patients/Hypogon 32174
)/The occurrence of progressive m 32199
) and acyclovir therapy/Regressio 32209
)/Transient self-resolving CMV vir 32241
/Hypotestosteronism in the era of 32275
)/Detection of genotypic drug resis 233*/32282
)/Virologic findings in patients with 32286
) leads to significant but delayed in 32317
is not hard enough - Virological fai 32319
)/Educational and support needs o 32333
) in the "real world": Experiences in 32334
) not prescribed or why is it disconti 446*/32335
): implications for adherence/comp 32356
)/Medication adherence enhance 32357
): levels in the clinical practice and 32367
)in patients infected with human im 32380
) among a Caribbean cohort of uns 32385
)/The value of early parameters of 32388
) for HIV infection/A multi-disciplin 32397
after sexual assault/Post-sexual e 250*/33174
on HIV viral load and CD4 T cells i 41185
+/- IL-2 on viral kinetics and T cell 41228
/Significance and therapeutic impli 42165
/Primary CNS lymphoma and 42404
)/A survey of the practice of prophy 42412
in private practice/Clinical and vir 42422
on health care utilization by HIV pa 42432
in clinical practice: The improveme 42437
) on the HIV/AIDS service delivery 43525
)is cost-effective compared to dela 44243
) and its effects on viral load (VL) a 60178
)/Evolution of CMV-PCR in the first 60180
) on cervical dysplasia and HPV inf 60289
)/Hepatitis B flare after highly activ 60323
): Who are they and why?/Patients 60336
in clinical trials vs. clinical care sett 60356
including antiprotease 6 months af 60510
is an unpredictable indicator of BC 60517
- A case study presentation/Com 60518
) adherence/Visual analogue scal 60535
/Community screening program to 60550
) in patients with HIV and tuberculo 60582
/The "steatosis-lactic acidosis syn 60611
therapy: 21 patients from Cook Co 60619
in the real world: The role of a phar 60621
/Spontaneous regressions of an A 60817

for progressive multifocal leucoen 60963
containing stavudine (d4T), lamivu 60998

scordant male couples/, attitudes, and risk behavior amon
ntiretroviral therapy ( )/Dynamic changes in naive and a
une reconstitution after (saquinavir-SGC, d4T and ddC) ini
+ patients: Influence of /Production of type-1, type-2 cytok
e antiretroviral therapy ( )/Patterns of cytokine production a
e antiretroviral therapy ( )/Bacillary angiomatosis in the sett
tion (SIR) after starting in AIDS patients treated for disse
rospective study in the era/Disseminated Mycobacterium
ntiretroviral therapy ( )/Skin test reactivity to Mycobacter
e antiretroviral therapy ( )/Manifestation of mycobacterial in
PCP) prophylaxis after in patients with AIDS/Withdrawal
tive patients/Impact of on clinical evolution of genital wart
AIDS patients following /Sustained disappearance of hum
ck of effect of long-term on hepatitis C (HCV) viremia/Lack
ediated/Evidence that induced immune recovery vitritis in
S-patients in the era of /Predictive value of cytomegalovir
ed patients treated with /Rapidly evolving hepatitis C virus
nt of CMV retinitis under despite termination of anti-CMV th
herapy after initiation of in 4 AIDS patients/Long-lasting re

643*/14136
269*/21112
21123
220*/21170
221*/21176
22114
22130
22168
22171
22172
22186
22192
14*/22237
18*/22238
15*/22240
22241
17*/22243
22260
22268

oplasia syndrome after haart initiation/Accelerated opportunistic i
e antiretroviral therapy ( HAAT ) on the incidence of oral candidosis/
ek cohort of 158 (HIV+) haemophilia patients/NHL - 17 years foil
Unaddressed needs of haemophiliacs with HIV in an area with lo
and HCV RNA levels in (Grehco Study)/Retrospe

60999
31217
22298
32437
42151